<?xml version="1.0" encoding="UTF-8"?>
<p>where 
 <italic>s
  <sub>x</sub>
 </italic> and 
 <italic>c
  <sub>A</sub>
 </italic> are the natural production and loss rate of AST, respectively, and 
 <italic>Î±</italic> is the rate of AST release by dying infected cells. We assumed four potential mechanisms of action for ribavirin that could (i) act as a mutagen limiting the infectivity of virions; (ii) reduce viral production; (iii) reduce cell loss by limiting inflammation; and (iv) increase cell loss by enhancing antiviral immunity.
</p>
